However, in another study that measured gene expression in whole blood (GEO: GSE172114; Figure S2D), we found that ATP11A expression was higher in patients diagnosed with critically ill COVID-19 when compared with those with non-critically ill COVID-19, which could be due to an increase in myeloid lineage cells. The gene discussed is ATP11A; the disease is COVID-19.